Can a new infusion drug shrink Hard-to-Treat tumors?
Disease control
Not yet recruiting
This early-stage trial is testing an investigational drug called SM2275 in people with advanced or metastatic solid tumors that have progressed after standard treatment or for which no standard therapy exists. The study aims to find the safest dose, understand how the drug behave…
Phase 1 • Sponsor: Beijing StarMab Biomed Technology Ltd • Aim: Disease control
Last updated Sep 09, 2026 16:00 UTC